First Look Analysts Research Calls for Friday, February 24
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Century Aluminum (CENX) upgraded to Peer Perform from Underperform at Wolfe Research > Esperion Therapeutics (ESPR) upgraded to Buy from Hold at Jefferies; tgt $12 > Grainger (GWW) upgraded…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Century Aluminum (CENX) upgraded to Peer Perform from Underperform at Wolfe Research
> Esperion Therapeutics (ESPR) upgraded to Buy from Hold at Jefferies; tgt $12
> Grainger (GWW) upgraded to Sector Perform from Underperform at RBC Capital Mkts; tgt raised to $679
> LyondellBasell (LYB) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $130
> NeoGenomics (NEO) upgraded to Buy from Hold at The Benchmark Company; tgt $20
> Youdao (DAO) upgraded to Buy from Hold at Jefferies; tgt raised to $10
Downgrades:
> C4 Therapeutics (CCCC) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $5
> CURO Group (CURO) downgraded to Underperform from Neutral at Credit Suisse; tgt lowered to $4
> Moderna (MRNA) downgraded to Underperform from Market Perform at SVB Securities; tgt lowered to $93
> Nektar Therapeutics (NKTR) downgraded to Underperform from Hold at Jefferies; tgt lowered to $1.50
> New York Mortgage Trust (NYMT) downgraded to Neutral from Buy at Ladenburg Thalmann
> OGE Energy (OGE) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $39
Others:
> Biomea Fusion (BMEA) initiated with a Buy at Citigroup; tgt $20
> Erasca (ERAS) initiated with a Buy at Goldman; tgt $10
> KE Holdings (BEKE) initiated with a Buy at Daiwa Securities
Contact [email protected] for any questions or corrections.